Investing in electroCore, Inc. (ECOR)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)9117.90144057
Intrinsic value (DCF)27336.25432094
Graham-Dodd Method0.00-100
Graham Formula0.00-100

Company description

ECOR, also known as electroCore, is a healthcare technology company that specializes in developing non-invasive neuromodulation therapies to improve patient outcomes. The company's flagship product is the gammaCore device, which uses a proprietary non-invasive vagus nerve stimulation technology to treat various neurological conditions such as migraines, cluster headaches, and asthma. Along with its innovative medical device, ECOR also offers a companion mobile app for patients to track their treatments and symptoms. The company has a strong focus on research and development, with multiple clinical trials ongoing to expand the indications for gammaCore. In addition to its current products, ECOR is continuously exploring new treatment applications and partnerships to better serve patients and healthcare providers. With a global presence and a mission to improve the lives of patients, ECOR is poised for future growth and success in the healthcare industry.